Nisha Aynikkattil Ravindran

Nisha Aynikkattil Ravindran

Auto-generated profile, based on publicly available information

Nisha Aynikkattil Ravindran

Professor and Head, Department of Veterinary Pharmacology and Toxicology, College of Veterinary and Animal Sciences University, Mannuthy -680651, Kerala, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in Proteomics – Clinical Applications
Verified
Journal Article
Closed access
AKAjeeshkumar Kizhakkeppurath Kumaran
Ajeeshkumar Kizhakkeppurath Kumaran
ASAnkita Sahu
Ankita Sahu
ASAstha Singh
Astha Singh
NRNisha Aynikkattil Ravindran
Nisha Aynikkattil Ravindran
NCNiladri Sekhar Chatterjee
Niladri Sekhar Chatterjee
SVSaurabh Varma
Saurabh Varma

15 August 2022 in The Journal of Phytopharmacology
Verified
Journal Article
Closed access
AXAdheena Xavier
Adheena Xavier
SRS Suja Rani
S Suja Rani
RSR Shankar
R Shankar
ANAr Nisha
Ar Nisha
SSSujith Samraj
Sujith Samraj
RUR Uma
R Uma
Essential oils, which are the plant derived secondary metabolites have been reported for various traditional medicinal applications. Amongst them, lemongrass oil (LGO) derived from Cymbopogon spp. as well as its major constituent citral possess a myriad of therapeutic potentials. The present study has been undertaken to study the adverse effects of LGO and citral on acute oral exposure to Sprague Dawley rats to establish the preliminary safety of these compounds prior to their efficacy evaluation against fatty liver disease. The toxicity study was conducted as per OECD guidelines No. 420. The LGO and citral were solubilized in 1% tween 80 and administered orally in a sequential manner in one animal at 2000 mg/kg (sighting study) followed by four animals (main study). The animals were then monitored for any clinical abnormalities or mortality and body weight gain during the observational period of 14- days, after which the animals were sacrificed and examined for abnormal lesions. LGO was further subjected to gas chromatography-mass spectrometry (GC-MS) analysis to characterize its chemical constituents, which revealed alpha and beta citral as the two major constituents. The rats treated with LGO and citral survived throughout the study period and didn’t exhibit any clinical abnormalities. Moreover, body weight gain was comparable to the vehicle treated rats and necropsy revealed no pathological alterations. Thus, the present study indicated LGO and citral as safe compounds with an LD50 greater than 2000 mg/kg and could be labelled as category 5/unclassified in hazard category of Globally harmonized system for classification of chemicals.

31 October 2024 in The Journal of Phytopharmacology
Verified
Journal Article
Closed access
ASAnoopa Satheesan
Anoopa Satheesan
SPSiyana Saleem P
Siyana Saleem P
SNSuresh N. Nair
Suresh N. Nair
BKBibu John Kariyil
Bibu John Kariyil
ANAr Nisha
Ar Nisha
KPKs Prasanna
Ks Prasanna
Background: Evaluating the wound healing potential of ligands present in a crude extract through molecular docking studies targeting TNF-α, IL-1β, and TGF-β1 is highly informative. TNF-α and IL-1β are key pro-inflammatory cytokines involved in the inflammatory phase of wound healing, whereas TGF-β1 plays a crucial role in tissue regeneration and remodelling. By assessing the binding affinity and interactions of the extract's phytochemicals with these proteins, valuable insights into the extract's potential anti-inflammatory and regenerative effects can be gained. This approach facilitates a targeted evaluation of the extract's capacity to modulate critical pathways in wound healing, thereby providing essential information for developing effective therapeutic agents. Aims and Objectives: Molecular docking studies on phytochemicals derived from the methanolic extract of Plectranthus amboinicus targeting TNF-α, IL-1β, and TGF-β1 provide insights into the potential wound healing efficacy of the Plectranthus amboinicus leaf extract, as reflected by the obtained docking scores. Materials and Methods: Chemical profiling of the methanolic leaf extract of Plectranthus amboinicus was conducted using GC-MS. In silico molecular docking studies with AutoDock4 were employed to evaluate the binding of these phytoconstituents to the active sites of three proteins associated with wound healing: TNF-α, TGF-β1, and IL-1β. Additionally, the pharmacokinetic properties of the active compounds were further assessed using the admetSAR software. Results and Conclusion: Of the compounds identified by GC-MS analysis, 13 exhibited promising binding scores, indicating a hopeful wound healing potential for the plant. AdmetSAR predictions further suggested that these phytoconstituents possess favourable absorption, distribution, and metabolism profiles, with low toxicity. Collectively, these findings suggest that the methanolic leaf extract of Plectranthus amboinicus holds significant wound healing activity.

30 January 2026 in The Journal of Phytopharmacology
Verified
Journal Article
Closed access
PPPallavi B. Pillai
Pallavi B. Pillai
BKBibu John Kariyil
Bibu John Kariyil
ANA.R. Nisha
A.R. Nisha
SNSuresh N. Nair
Suresh N. Nair
MSM Shynu
M Shynu
SDSs Devi
Ss Devi
Background: Medicinal plants are an important source of bioactive compounds with significant therapeutic potential, forming the basis of many traditional and modern pharmacological preparations. Tragia involucrata and Psidium guajava are widely used in traditional medicine for treating gastrointestinal, respiratory, metabolic, and infectious conditions. Despite their traditional relevance, a detailed chemical characterization of specific solvent fractions, particularly using advanced analytical methods, remains limited. Gas chromatography–mass spectrometry (GC-MS) offers a powerful tool for the identification of volatile and semi-volatile phytochemicals that may contribute to the pharmacological properties of these plants. Objective: This study aimed to identify and characterize the bioactive phytoconstituents present in the hexane fraction of Tragia involucrata whole plant and the methanol fraction of Psidium guajava leaves using GC-MS analysis, and to highlight their potential pharmacological relevance. Materials and Methods: Whole plant material of T. involucrata and leaves of P. guajava were collected from Kollam, Kerala, authenticated through DNA barcoding, shade-dried, powdered, and extracted using methanol. The crude extracts were successively fractionated with solvents of increasing polarity, and the hexane fraction of T. involucrata and methanol fraction of P. guajava were selected for GC-MS profiling. Analyses were carried out using a Shimadzu Nexus GC-2030 system under optimized temperature and carrier gas conditions. Compounds were identified based on retention time, mass spectral data, and comparison with the NIST 20 library. Results: GC-MS analysis of the T. involucrata hexane fraction identified fourteen phytoconstituents representing diverse chemical classes. These included alkylated phenols (2,4-di-tert-butylphenol; benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy, methyl ester), terpenoids (neophytadiene), diterpene alcohols (3,7,11,15-tetramethyl-2-hexadecen-1-ol), and fatty acid derivatives such as hexadecanoic acid methyl ester, methyl stearate, 9,12-octadecadienoic acid (Z,Z) methyl ester, 9,12,15-octadecatrienoic acid (Z,Z,Z) methyl ester, and n-hexadecanoic acid. Higher-chain esters, including hexadecanoic acid bis(2-ethylhexyl) ester, were also present. Additionally, phytol, squalene, and the antioxidant dl-α-tocopherol were detected, reflecting the chemical richness and potential bioactivity of the extract. The methanol fraction of P. guajava identified 10 bioactive compounds, predominantly saturated fatty acids (tetradecanoic, pentadecanoic, octadecanoic acids, oleic acid), long-chain hydrocarbons (dotriacontane, pentacosane), triterpene (squalene) and saturated fatty acids namely 13-docosenamide, and tetradecyl palmitate. The presence of these structurally diverse metabolites in both the T. involucrata hexane fraction and the P. guajava methanolic fraction highlights their notable phytochemical abundance and potential relevance for broad pharmacological applications. Conclusion: GC-MS profiling of T. involucrata and P. guajava demonstrates a diverse array of pharmacologically important metabolites, including diterpenes, terpenoids, phenolic derivatives, fatty acid esters, squalene, and α-tocopherol. These findings support their traditional medicinal relevance and indicate their promise as sources of bioactive lead molecules for drug development. Further biological evaluation is recommended to validate their therapeutic potential.

8 May 2026 in The Journal of Phytopharmacology
Verified
Journal Article
Closed access
PVPooja Krishna Kizhekku Veettil
Pooja Krishna Kizhekku Veettil
SSSuja Rani Sasidharan
Suja Rani Sasidharan
NRNisha Ayinikkattil Ravindran
Nisha Ayinikkattil Ravindran
PJPreethy John
Preethy John
ARAnoopraj Rajappan
Anoopraj Rajappan
RVReji Varghese
Reji Varghese
Background: Multidrug-resistant Staphylococcus aureus (MDRSA) infections significantly impair wound healing, often leading to chronic wounds and systemic complications. There is a need for wound dressings that are not only antibacterial but also biocompatible. Essential oils, such as eugenol, possess potent antibacterial properties, but their direct application is limited by volatility and instability. Incorporating eugenol into a polymeric hydrogel provides a stable delivery system, while ensuring safety prior to in vivo use is essential. Objectives: This study aimed to evaluate the dermal safety of eugenol-incorporated chitosan-PVA hydrogel (Eug-CH) in Sprague Dawley rats, following OECD Test Guideline 402. Materials and Methods: The inert chitosan-PVA hydrogel was synthesised via chemical crosslinking, followed by incorporation of eugenol as an emulsion. Acute dermal toxicity testing was conducted according to OECD 402, with topical application to the dorsal skin under semi-occlusive conditions. Sequential doses up to 2000 mg/kg were administered, with a total of five female rats used. Animals were monitored intensively for 24 h post-application and daily for 14 days, assessing dermal integrity, behaviour and systemic signs of toxicity. Results: Topical application of Eug-CH produced no mortality or toxicity at doses up to the tested limit dose of 2000 mg/kg. Observations over 14 days revealed no adverse effects, including erythema, edema, tremors, convulsions, or behavioural abnormalities. Gross necropsy showed no organ abnormalities and a normal increase in body weight was noted. These findings indicate that the Eug-CH formulation is safe for dermal application in rats even upto the limit dose level. Conclusion: The Eug-CH hydrogel showed no mortality, skin irritation or pathological changes at doses ranging from 200 to 2000 mg/kg, with normal body weight gain observed over 14 days. With an LD₅₀ exceeding 2000 mg/kg, the formulation is classified as GHS Category 5 (low hazard), confirming its safety for regulatory purposes. These results indicate that the eugenol incorporated hydrogel is highly biocompatible and suitable as an antibacterial wound dressing without risk of dermal toxicity.

17 April 2026 in The Journal of Phytopharmacology
Verified
Journal Article
Open access
JNJhancirani Neelamegam
Jhancirani Neelamegam
PJPreethy John
Preethy John
NRNisha Aynikkattil Ravindran
Nisha Aynikkattil Ravindran
SSSuja Rani Sasidharan
Suja Rani Sasidharan
ISIndira Sukumaran Sajitha
Indira Sukumaran Sajitha
PDPratheesh Mankuzhy Damodaran
Pratheesh Mankuzhy Damodaran
Background: Medicinal plants are valuable sources of structurally diverse bioactive compounds that contribute significantly to drug discovery and development. Manilkara zapota has been traditionally used for various therapeutic purposes; however, comprehensive chemical characterization of its leaf extract remains limited. Objective: To preliminary phytochemical screening to determine the main classes of secondary metabolites in the extract, along with the determination of predominant functional groups by FTIR spectroscopy and the identification of bioactive compounds using GC-MS to explore the chemical composition of extract. Materials and Methods: Shade-dried leaves of M. zapota were extracted with methanol using a Soxhlet apparatus. Co-extracted latex constituents were removed by acid-induced coagulation. Preliminary phytochemical screening was performed on both latex-removed and untreated extracts. FTIR spectroscopy was employed to identify major functional groups, while GC-MS analysis was carried out to characterise bioactive constituents. Results: Qualitative screening revealed the presence of steroids, terpenoids, alkaloids, tannins, phenolic compounds, flavonoids and saponins. FTIR analysis confirmed the presence of functional groups corresponding to alcohols, alkanes, conjugated alkenes and esters. GC–MS analysis identified several bioactive compounds, including glycopeptide derivatives, phenolic compounds, fatty acid esters, monoglycerides and terpenoid constituents. Conclusion: The findings demonstrate that M. zapota leaves are rich in diverse phytochemicals, supporting their potential therapeutic applications.